Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Svetlana Chernyavsky"'
Publikováno v:
Journal of Scientific Innovation in Medicine, Vol 4, Iss 2 (2021)
Background: COVID-19 disease caused by SARS-CoV-2 can lead to severe disease with pneumonia, respiratory failure, and death. Pathologic mechanisms include systemic inflammation with elevated IL-6 level. Glucocorticosteroids and Tocilizumab (TCZ), a m
Externí odkaz:
https://doaj.org/article/0739f9fbe89d4bf98a9a702835379383
Publikováno v:
Journal of Scientific Innovation in Medicine, Vol 3, Iss 3 (2020)
Externí odkaz:
https://doaj.org/article/b6bef8e22ee8435997d7726571c27d30
Publikováno v:
Journal of Scientific Innovation in Medicine, Vol 2, Iss 2 (2019)
Externí odkaz:
https://doaj.org/article/32840c6b6500404fb157da9194ff668e
Autor:
Carolina Villarroel, Silpa Yarra, Andre Khazak, Gres Karim, Trina Wijangco, Svetlana Chernyavsky
Publikováno v:
American Journal of Gastroenterology. 117:e1456-e1457
Publikováno v:
American Journal of Gastroenterology. 117:e1404-e1404
Autor:
Satoshi Miyashita, Hirotaka Miyashita, Takayuki Yamada, Nitin Chopra, Svetlana Chernyavsky, Takahisa Mikami
Publikováno v:
International Journal of Clinical Practice
Dear Editor,Since December 2019, coronavirus 2019 (COVID-19) has spread worldwide.1 Some data have suggested that the prevalence and mortality of COVID-19 are different among races. 2However, this analysis did not account for potential confounding fa
Autor:
Svetlana Chernyavsky, Olga Busko
Publikováno v:
Proceedings of the Kuban State Agrarian University. 1:19-24
Publikováno v:
American Journal of Gastroenterology. 116:S739-S740
Publikováno v:
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 7(12):ofaa558
Open Forum Infectious Diseases, 7(12):ofaa558
Short-course glucocorticosteroids are being used and tocilizumab (TCZ) had been used to treat patients with severe coronavirus disease 2019 (COVID-19) disease. These agents, when administered individually, have been associated with tuberculosis (TB)